Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.23 -0.02 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Sonoma Pharmaceuticals (SNOA) recorded Return on Capital Employed [ROCE] of -13.28% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 25.79 percentage points from -39.07% a year earlier and up 14.19 percentage points from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Sonoma Pharmaceuticals reported Return on Capital Employed [ROCE] of -27.36%, up 9.30 percentage points from FY2025.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +4.88 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -36.66% in FY2025 (+3.29 pp), -39.95% in FY2024 (-6.89 pp), -33.07% in FY2023 (+19.98 pp) and -53.05% in FY2022 (-20.80 pp).
  • The fiscal Q1 2027 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q1 2012.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for six consecutive quarters, with an average year-over-year change of +9.15 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 25.79 percentage points in fiscal Q1 2027, against a drop of 25.75 percentage points in fiscal Q3 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -27.47% (Q4 2026), -29.05% (Q3 2026) and -31.50% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Sonoma Pharmaceuticals 4.73 Mn -8.60 Mn 2.58 Mn -13.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.28%
Mar 31, 2026 -27.47%
Dec 31, 2025 -29.05%
Sep 30, 2025 -31.50%
Jun 30, 2025 -39.07%
Mar 31, 2025 -38.71%
Dec 31, 2024 -44.75%
Sep 30, 2024 -41.23%
Jun 30, 2024 -44.32%
Mar 31, 2024 -42.89%
Dec 31, 2023 -40.16%
Sep 30, 2023 -47.11%
Jun 30, 2023 -41.19%
Mar 31, 2023 -40.19%
Dec 31, 2022 -61.65%
Sep 30, 2022 -44.71%
Jun 30, 2022 -44.40%
Mar 31, 2022 -44.33%
Dec 31, 2021 -35.89%
Sep 30, 2021 -37.37%
API Access

Sonoma Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNOA&period=max&api_key=YOUR_API_KEY